APGE vs BIIB: Which Stock is Better?
Side-by-side comparison of Apogee Therapeutics Inc and Biogen Inc in 2026
APGE
Apogee Therapeutics Inc
$74.68
BIIB
Biogen Inc
$190.48
Key Metrics Comparison
| Metric | APGE | BIIB | Winner |
|---|---|---|---|
| Market Cap | $5.19B | $27.95B | BIIB |
| P/E Ratio | N/A | 21.40 | BIIB |
| EPS (TTM) | $N/A | $8.90 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze APGE
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APGE or BIIB a better investment?
Comparing APGE and BIIB: Apogee Therapeutics Inc has a market cap of $5.19B while Biogen Inc has $27.95B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APGE and BIIB?
APGE (Apogee Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APGE or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APGE or BIIB?
APGE has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: APGE or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for APGE.
Which is the larger company: APGE or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.95B compared to $5.19B for APGE.
Should I buy APGE or BIIB in 2026?
Both APGE and BIIB have investment merit. APGE trades at $74.68 while BIIB trades at $190.48. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APGE and BIIB stock?
Key differences: Market Cap ($5.19B vs $27.95B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).